Product Overview: Beloc ZOK 100 AstraZeneca
Beloc ZOK 100 AstraZeneca is a pharmaceutical-grade metoprolol succinate formulation developed by AstraZeneca for investigational studies examining selective beta-1 adrenergic receptor antagonism in cardiovascular research models. This sustained-release preparation enables researchers to evaluate the pharmacokinetic profile and beta-blocking properties of metoprolol succinate in controlled laboratory environments. The compound demonstrates selective affinity for beta-1 adrenergic receptors, making it valuable for studies investigating cardiovascular physiology and adrenergic system modulation. Researchers at Stroid UK Shop can access this pharmaceutical reference standard for comprehensive cardiovascular research applications requiring precise beta-blocker compounds.
Laboratory Applications
This metoprolol succinate preparation serves multiple research applications in cardiovascular and pharmacological studies. Research teams examine its selective beta-1 receptor antagonism properties in cardiac tissue models, investigating mechanisms of heart rate modulation and myocardial contractility effects. The sustained-release formulation allows for extended pharmacokinetic studies, enabling researchers to analyse drug release profiles and bioavailability characteristics over extended timeframes. Comparative studies utilise this compound alongside other metoprolol preparations to evaluate formulation differences and therapeutic equivalence. Additionally, researchers investigate its potential interactions with other cardiovascular compounds, including comparative analyses with research compounds available in SARMs categories and peptide research for comprehensive cardiovascular research protocols.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Metoprolol Succinate |
| Strength | 100mg per unit |
| Formulation | Extended-release tablet |
| Manufacturer | AstraZeneca |
| Storage Conditions | Room temperature, dry environment |
| Research Applications | Cardiovascular, pharmacokinetic studies |
Research Compliance
Beloc ZOK 100 AstraZeneca is supplied exclusively for in-vitro research applications and laboratory analysis. This pharmaceutical preparation is not intended for human consumption, therapeutic use, or any clinical applications. Research institutions must maintain appropriate laboratory protocols when handling this compound and ensure compliance with institutional research guidelines. All studies involving this metoprolol succinate preparation should be conducted under controlled laboratory conditions with proper safety measures and documentation procedures as required for cardiovascular research compounds.
